A recent survey of nearly 100 employers regarding their worker’s compensation policies and practices, conducted by Occupational Health & Safety and Injury Management Partners LLC, demonstrated some ...

A new editorial in JAMA Cardiology has rekindled discussions about the role of aspirin for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD) and whether there’s a ...

For adults who have survived a heart attack or stroke, taking aspirin regularly may reduce the risk of another cardiovascular event. But a new study suggests that less than half of these ...

Among patients with ­cardiovascular disease (CVD) in 17 countries, many receive no medication for secondary prevention, a study showed. Overall use of medications for secondary prevention decreased ...

Ischemic heart disease and stroke are the leading causes of death worldwide. A large proportion of individuals at high 10-year risk of a cardiovascular event live in low-income and middle-income ...

Research presented at the 2024 European Society of Cardiology Congress explored gender-based care and outcomes disparities, with potential implications for health care policy and equitable care of ...

Across the world, many patients with CVD still aren’t on the recommended medications for secondary prevention, according to more than a decade’s worth of data from the 17-country Prospective Urban ...

Background: Proven efficacious therapies are sometimes underused in patients with chronic cardiac conditions, resulting in suboptimal outcomes. We evaluated whether evidence summaries, which were ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Atherosclerotic CVD has long been recognized as an ...